Ania Jastreboff, MD, PhD

Yale University School of Medicine

Presentation(s):

• Recent Advances in the Treatment of Obesity

  Thursday, September 15, 2022
  1:00 PM – 2:30 PM ET

  Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Intellihealth: Consultant (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Novo Nordisk AS: Consultant (Ongoing)
  Pfizer: Consultant (Ongoing)
  Rhythm Pharmaceuticals: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Scholar Rock: Consultant (Ongoing)
  WWF International: Consultant (Ongoing)

• Anti-obesity Pharmacotherapy: The Future Is Now!

  Thursday, September 15, 2022
  1:00 PM – 1:40 PM ET

  Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Intellihealth: Consultant (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Novo Nordisk AS: Consultant (Ongoing)
  Pfizer: Consultant (Ongoing)
  Rhythm Pharmaceuticals: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Scholar Rock: Consultant (Ongoing)
  WWF International: Consultant (Ongoing)

• Panel Discussion - Recent Advances in the Treatment of Obesity

  Thursday, September 15, 2022
  2:00 PM – 2:30 PM ET

  Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Intellihealth: Consultant (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Novo Nordisk AS: Consultant (Ongoing)
  Pfizer: Consultant (Ongoing)
  Rhythm Pharmaceuticals: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Scholar Rock: Consultant (Ongoing)
  WWF International: Consultant (Ongoing)